BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18480323)

  • 1. Clostridium difficile toxin synthesis is negatively regulated by TcdC.
    Dupuy B; Govind R; Antunes A; Matamouros S
    J Med Microbiol; 2008 Jun; 57(Pt 6):685-689. PubMed ID: 18480323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile toxin expression is inhibited by the novel regulator TcdC.
    Matamouros S; England P; Dupuy B
    Mol Microbiol; 2007 Jun; 64(5):1274-88. PubMed ID: 17542920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular methods to study transcriptional regulation of Clostridium difficile toxin genes.
    Antunes A; Dupuy B
    Methods Mol Biol; 2010; 646():93-115. PubMed ID: 20597005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production.
    Merrigan M; Venugopal A; Mallozzi M; Roxas B; Viswanathan VK; Johnson S; Gerding DN; Vedantam G
    J Bacteriol; 2010 Oct; 192(19):4904-11. PubMed ID: 20675495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The C-Terminal Domain of Clostridioides difficile TcdC Is Exposed on the Bacterial Cell Surface.
    Oliveira Paiva AM; de Jong L; Friggen AH; Smits WK; Corver J
    J Bacteriol; 2020 Oct; 202(22):. PubMed ID: 32868401
    [No Abstract]   [Full Text] [Related]  

  • 6. TcdC does not significantly repress toxin expression in Clostridium difficile 630ΔErm.
    Bakker D; Smits WK; Kuijper EJ; Corver J
    PLoS One; 2012; 7(8):e43247. PubMed ID: 22912837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile.
    Hundsberger T; Braun V; Weidmann M; Leukel P; Sauerborn M; von Eichel-Streiber C
    Eur J Biochem; 1997 Mar; 244(3):735-42. PubMed ID: 9108241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A.
    Murray R; Boyd D; Levett PN; Mulvey MR; Alfa MJ
    BMC Infect Dis; 2009 Jun; 9():103. PubMed ID: 19558711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RstA Is a Major Regulator of Clostridioides difficile Toxin Production and Motility.
    Edwards AN; Anjuwon-Foster BR; McBride SM
    mBio; 2019 Mar; 10(2):. PubMed ID: 30862746
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of the pathogenicity locus in Clostridium difficile strains.
    Cohen SH; Tang YJ; Silva J
    J Infect Dis; 2000 Feb; 181(2):659-63. PubMed ID: 10669352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of Clostridium difficile toxin gene expression by CodY.
    Dineen SS; Villapakkam AC; Nordman JT; Sonenshein AL
    Mol Microbiol; 2007 Oct; 66(1):206-19. PubMed ID: 17725558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple factors contribute to bimodal toxin gene expression in Clostridioides (Clostridium) difficile.
    Ransom EM; Kaus GM; Tran PM; Ellermeier CD; Weiss DS
    Mol Microbiol; 2018 Nov; 110(4):533-549. PubMed ID: 30125399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The second messenger cyclic Di-GMP regulates Clostridium difficile toxin production by controlling expression of sigD.
    McKee RW; Mangalea MR; Purcell EB; Borchardt EK; Tamayo R
    J Bacteriol; 2013 Nov; 195(22):5174-85. PubMed ID: 24039264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile: New Insights into the Evolution of the Pathogenicity Locus.
    Monot M; Eckert C; Lemire A; Hamiot A; Dubois T; Tessier C; Dumoulard B; Hamel B; Petit A; Lalande V; Ma L; Bouchier C; Barbut F; Dupuy B
    Sci Rep; 2015 Oct; 5():15023. PubMed ID: 26446480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis and genotyping of pathogenicity locus in Clostridioides difficile strains isolated from patients in Tehran hospitals during the years 2007-2010.
    Azimirad M; Azizi O; Alebouyeh M; Aslani MM; Mousavi SF; Zali MR
    Infect Genet Evol; 2019 Jul; 71():205-210. PubMed ID: 30902742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mathematical modelling reveals properties of TcdC required for it to be a negative regulator of toxin production in Clostridium difficile.
    Jabbari S; Cartman ST; King JR
    J Math Biol; 2015 Mar; 70(4):773-804. PubMed ID: 24687436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic relatedness of Clostridium difficile isolates from various origins determined by triple-locus sequence analysis based on toxin regulatory genes tcdC, tcdR, and cdtR.
    Bouvet PJ; Popoff MR
    J Clin Microbiol; 2008 Nov; 46(11):3703-13. PubMed ID: 18832125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CdtR Regulates TcdA and TcdB Production in Clostridium difficile.
    Lyon SA; Hutton ML; Rood JI; Cheung JK; Lyras D
    PLoS Pathog; 2016 Jul; 12(7):e1005758. PubMed ID: 27414650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection.
    Persson S; Torpdahl M; Olsen KE
    Clin Microbiol Infect; 2008 Nov; 14(11):1057-64. PubMed ID: 19040478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe.
    Warny M; Pepin J; Fang A; Killgore G; Thompson A; Brazier J; Frost E; McDonald LC
    Lancet; 2005 Sep 24-30; 366(9491):1079-84. PubMed ID: 16182895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.